Tomer Kariv, Director, 10% Owner at Keros Therapeutics, Inc. (KROS), bought 1,801,041 shares at $16.00 ($7.0M) on 2020-04-13, disclosed to the SEC on 2020-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,363,542 | $0 | 0.0% |
| 2 | $16.00 | 43,750 | $700K | 10.0% |
| 3 | $16.00 | 94,546 | $1.5M | 21.6% |
| 4 | $16.00 | 105,000 | $1.7M | 24.0% |
| 5 | $16.00 | 194,203 | $3.1M | 44.4% |
| Total | $3.89 avg | 1,801,041 |
| $7.0M |
| 100% |
| Filing → |
| VBIV | BUY | 2018-12-18 | $4.0M | — | Filing → |
| LOGC | BUY | 2018-10-25 | $4.2M | — | Filing → |
| ELOX | BUY | 2018-05-01 | $6.8M | — | Filing → |